XML 34 R18.htm IDEA: XBRL DOCUMENT v3.25.3
Note 2 - Basis of Presentation, Principles of Consolidation, and Significant Accounting Policies and Liquidity (Tables)
9 Months Ended
Sep. 30, 2025
Notes Tables  
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
  

September 30, 2025

  

December 31, 2024

 

Prepaid insurance

 $786  $554 

Vendor prepayments and deposits

  367   331 

Prepaid sponsored research

  23   11 

Related party receivables

  4   4 

Non-trade receivables

  2   16 

Total prepaid expenses and other current assets

 $1,182  $916 
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]

Description

 

Fair Value

  

Level 1

  

Level 2

  

Level 3

 

Fair value of warrant liability as of September 30, 2025:

 $41,333  $  $  $41,333 

Fair value of warrant liability as of December 31, 2024:

 $  $  $  $ 

Three Months Ended September 30, 2025

 

Warrant Liability Long-Term

 

Balance, June 30, 2025

 $16,830 

Warrants issued

  30,585 

Warrants exercised

  (4,491)

Change in fair value - net

  (1,591)

Balance, September 30, 2025

 $41,333 

Nine Months Ended September 30, 2025

 

Warrant Liability Long-Term

 

Balance, December 31, 2024

 $ 

Warrants issued

  46,855 

Warrants exercised

  (4,491)

Change in fair value - net

  (1,031)

Balance, September 30, 2025

 $41,333 
Accounting Standards Update and Change in Accounting Principle [Table Text Block]
  

September 30, 2025

  

December 31, 2024

 
  

 

  

As Reported

  

Effect of

  

As Reported

  

As Adjusted

  

Effect of

 
  Under Old Policy  Under New Policy  Change  Under Old Policy  Under New Policy  Change 

Condensed Consolidated Balance Sheets

                        

Warrant liability - long-term

 $48,660  $41,333  $(7,327) $5,229  $  $(5,229)

Total liabilities

  54,600   47,273   (7,327)  10,946   5,717   (5,229)

Additional paid-in capital

  162,337   194,631   32,294   159,384   183,690   24,306 

Accumulated deficit

  (196,589)  (221,556)  (24,967)  (153,367)  (172,444)  (19,077)

Total stockholders' equity (deficit)

  (34,247)  (26,920)  7,327   5,979   11,208   5,229 

Total liabilities and stockholders' equity (deficit)

  20,353   20,353      16,925   16,925    
  

March 31, 2025

  

June 30, 2025

 
  

As Reported

  

As Adjusted

  

Effect of

  

As Reported

  

As Adjusted

  

Effect of

 
  

Under Old Policy

  

Under New Policy

  

Change

  

Under Old Policy

  

Under New Policy

  

Change

 

Condensed Consolidated Balance Sheets

                        

Warrant liability - long-term

 $13,749  $  $(13,749) $20,553  $16,973  $(3,580)

Total liabilities

  20,971   7,222   (13,749)  28,758   25,178   (3,580)

Additional paid-in capital

  159,869   192,163   32,294   160,286   192,580   32,294 

Accumulated deficit

  (159,803)  (178,348)  (18,545)  (167,443)  (196,157)  (28,714)

Total stockholders' equity (deficit)

  42   13,791   13,749   (7,165)  (3,585)  3,580 

Total liabilities and stockholders' equity (deficit)

  21,013   21,013      21,593   21,593    
  Three Months Ended  Three Months Ended 
  

September 30, 2025

  

September 30, 2024

 
  

 

  

As Reported

  

Effect of

  

As Reported

  

As Adjusted

  

Effect of

 
  

Under Old Policy

  

Under New Policy

  

Change

  

Under Old Policy

  

Under New Policy

  

Change

 

Condensed Consolidated Statement of Operations

      

Gain (loss) from change in fair value of warrant liability

 $(2,157) $1,591  $3,748  $(1,728) $  $1,728 

Transaction costs allocated to warrant liabilities

  (530)  (530)     (993)     993 

Loss on issuance of warrant liabilities

  (20,609)  (20,609)     (847)     847 

Net loss

  (29,147)  (25,399)  3,748   (10,592)  (7,024)  3,568 

Net loss per common share - basic and diluted

  (0.78)  (0.68)  0.10   (2.85)  (1.89)  0.96 

Other comprehensive income (loss)

  (29,153)  (25,405)  3,748   (10,578)  (7,010)  3,568 
  Nine Months Ended  Nine Months Ended 
  

September 30, 2025

  

September 30, 2024

 
  

 

  

As Reported

  

Effect of

  

As Reported

  

As Adjusted

  

Effect of

 
  

Under Old Policy

  

Under New Policy

  

Change

  

Under Old Policy

  

Under New Policy

  

Change

 

Condensed Consolidated Statement of Operations

      

Gain (loss) from change in fair value of warrant liability

 $16,506  $1,031  $(15,475) $1,423  $  $(1,423)

Transaction costs allocated to warrant liabilities

  (3,525)  (1,737)  1,788   (993)     993 

Loss on issuance of warrant liabilities

  (38,760)  (30,962)  7,798   (847)     847 

Net loss

  (43,223)  (49,112)  (5,889)  (19,881)  (19,464)  417 

Net loss per common share - basic and diluted

  (2.08)  (2.36)  (0.28)  (6.83)  (6.69)  0.14 

Other comprehensive income (loss)

  (43,226)  (49,115)  (5,889)  (19,868)  (19,451)  417 
  

Three Months Ended

  

Three Months Ended

 
  

June 30, 2025

  

June 30, 2024

 
  

As Reported

  

As Adjusted

  

Effect of

  

As Reported

  

As Adjusted

  

Effect of

 
  

Under Old Policy

  

Under New Policy

  

Change

  

Under Old Policy

  

Under New Policy

  

Change

 

Condensed Consolidated Statement of Operations

                        

Gain (loss) from change in fair value of warrant liability

 $9,609  $(560) $(10,169) $1,696  $  $(1,696)

Transaction costs allocated to warrant liabilities

  (1,207)  (1,207)            

Loss on issuance of warrant liabilities

  (10,352)  (10,352)            

Net loss

  (7,640)  (17,809)  (10,169)  (4,319)  (6,015)  (1,696)

Net loss per common share - basic and diluted

  (0.49)  (1.15)  (0.66)  (1.70)  (2.37)  (0.67)

Other comprehensive loss

  (7,640)  (17,809)  (10,169)  (4,311)  (6,007)  (1,696)
  

Six Months Ended

  

Six Months Ended

 
  

June 30, 2025

  

June 30, 2024

 
  

As Reported

  

As Adjusted

  

Effect of

  

As Reported

  

As Adjusted

  

Effect of

 
  Under Old Policy  Under New Policy  Change  Under Old Policy  Under New Policy  Change 

Condensed Consolidated Statement of Operations

                        

Gain (loss) from change in fair value of warrant liability

 $18,663  $(560) $(19,223) $3,151  $  $(3,151)

Transaction costs allocated to warrant liabilities

  (2,995)  (1,207)  1,788          

Loss on issuance of warrant liabilities

  (18,150)  (10,352)  7,798          

Net loss

  (14,076)  (23,713)  (9,637)  (9,289)  (12,440)  (3,151)

Net loss per common share - basic and diluted

  (1.13)  (1.90)  (0.77)  (3.71)  (4.97)  (1.26)

Other comprehensive loss

  (14,073)  (23,710)  (9,637)  (9,290)  (12,441)  (3,151)
  

Three Months Ended

  

Three Months Ended

 
  

March 31, 2025

  

March 31, 2024

 
  

As Reported

  

As Adjusted

  

Effect of

  

As Reported

  

As Adjusted

  

Effect of

 
  

Under Old Policy

  

Under New Policy

  

Change

  

Under Old Policy

  

Under New Policy

  

Change

 

Condensed Consolidated Statement of Operations

                        

Gain from change in fair value of warrant liability

 $9,054  $  $(9,054) $1,455  $  $(1,455)

Transaction costs allocated to warrant liabilities

  (1,788)     1,788          

Loss on issuance of warrant liabilities

  (7,798)     7,798          

Net loss

  (6,436)  (5,904)  532   (4,970)  (6,425)  (1,455)

Net loss per common share - basic and diluted

  (0.69)  (0.63)  0.06   (2.02)  (2.61)  (0.59)

Other comprehensive loss

  (6,433)  (5,901)  532   (4,979)  (6,434)  (1,455)